Featured new tests in quarter one of 2025
Featured new tests
In the first quarter of 2025, Mayo Clinic Laboratories expanded its test catalog with several innovative new tests, including:
- LUCHM | LiquidHALLMARK ctDNA and ctRNA
- As an alternative to invasive tissue biopsies to assist in tumor profiling for diagnosis, predicting prognosis, and identifying targeted therapies for the treatment and management of patients with a solid tumor.
In this episode of “Answers From the Lab,” William Morice II, M.D., Ph.D., CEO and president of Mayo Clinic Laboratories, invited Min-Han Tan, M.B.B.S., FRCP, Ph.D., founding CEO and medical director of Lucence, to discuss liquid biopsy cancer testing. Mayo Clinic Laboratories and Lucence recently announced a collaboration to expand access to this cutting-edge cancer test that is designed to detect clinically relevant biomarkers in ctDNA and ctRNA.
Mayo Clinic Laboratories and Lucence are expanding access to advanced cancer testing worldwide with LiquidHALLMARK®, a next-generation liquid biopsy that provides actionable genomic insights. This collaboration empowers physicians to deliver personalized care and improve patient outcomes.
- KITQ | KIT p.Asp816Val Variant Analysis, Quantitative, Varies
- Diagnosing systemic mastocytosis.
- NEUD1 | Neuronal Differentiation 1 (NeuroD1), Technical Component only
- Subclassification of small cell lung carcinoma.
- NAACD | N-Acetylaspartic Acid, Canavan Disease, Random, Urine
- Diagnosis and monitoring of individuals with Canavan disease.
- Follow-up quantitation of abnormal organic acid elevations of N-acetylaspartic acid.
- AACYL | Aminoacylase-1 Deficiency, Urine
- Follow-up quantitation of abnormal organic acid elevations of N-acetylated amino acids, in particular N-acetylalanine, N-acetylglycine, N-acetylmethionine, and N-acetylglutamic acid.
- Diagnosis of individuals with aminoacylase-1 deficiency.
- Evaluating patients with neurologic and psychiatric symptoms of unknown etiology.
- CMVLR | Cytomegalovirus (CMV) Molecular Detection, PCR, Lower Respiratory
- Rapid qualitative detection of cytomegalovirus (CMV) DNA in lower respiratory specimens.
- K818 | Keratin 8 and 18 (KRT8/18), Technical Component only
- Aiding in the diagnosis of carcinomas.
Visit our test catalog for more information on new or updated tests and testing algorithms.
